OrphanDrug
OrphanDrug
Pharma Knowledge Base

Hemihyperplasia–multiple lipomatosis syndrome

ORPHA: 276280

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with Hemihyperplasia–multiple lipomatosis syndrome, sourced from HPO and Orphanet clinical annotations.

OvergrowthMacrodactylyAbnormal cerebral vascular morphologyHydrocele testisEnlarged kidneyMultiple lipomasSeborrheic dermatitisFoot polydactylyAbnormal venous morphologyScoliosisNevusMicrotia2-4 toe syndactylyOvarian serous cystadenomaHyperparakeratosisLipoatrophyTelangiectasia of the skinAbnormality of the lymphatic systemNephroblastoma

Classification & Codes

Orphanet Code

ORPHA:276280
Hemihyperplasia–multiple lipomatosis syndrome
OrphanetORPHA:276280
Treatments0 drug(s)
Symptoms on record19 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO